Column Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q2  | $35.9M | Hold | 
         | 
    |||||
| 
        
          
      
        2025
         Q1  | $19.8M | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $28.6M | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $36.3M | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $25M | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $48.7M | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $32.8M | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $21.6M | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $27.7M | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $20.3M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $21M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $11.4M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $16M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $19.1M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $52.5M | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $99.7M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $84.3M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $117M | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $161M | Buy | 
         |